[Tumor suppressing effect of systemic hyperthermia with 2350 MHz microwaves combined with 5-fluorouracil in mice]. 1983

T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii

C3H/He mice were inoculated i.p. with syngeneic MM2 tumor cells (2 X 10(6) cells/mouse), and they were subsequently treated by systemic hyperthermia with microwave irradiation (2450 MHz) alone, administration of 5-FU alone, or a combination of the both. The mice were exposed to hyperthermia for 5 minutes everyday with an output of 10, 20 or 30 watts. 5-FU was administered i.p. for 3 days at dose levels of 2.5 mg/kg, 5 mg/kg or 10 mg/kg body weight. The mean survival time and the mean relative body weight were recorded. From these data, tumor-suppressing effects of the treatments were analyzed by one-way variance analysis or two-way variance analysis. The mice treated with microwave irradiation alone or 5-FU alone survived significantly longer than the control mice receiving no treatment (P less than 0.01). However, no significant difference in mean survival time was observed between the microwave group and the 5-FU group. The mean relative body weight was similar among the microwave, the 5-FU and the control group. When the mice were treated with microwave irradiation and 5-FU, significant difference was observed in the mean survival time (P less than 0.01), and the combination of microwave irradiation with an output of 20 W and 10 mg/kg of 5-FU seemed to be optimal. Determination of an optimal combination was difficult with the mean relative body weight, because body weight decreased due to side effect of the combination therapy.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008872 Microwaves That portion of the electromagnetic spectrum from the UHF (ultrahigh frequency) radio waves and extending into the INFRARED RAYS frequencies. EHF Waves,Extremely High Frequency Radio Waves,Micro Wave,Micro Waves,Ultrahigh Frequency Waves,Microwave Radiation,EHF Wave,Micro Waves,Microwave,Microwave Radiations,Radiation, Microwave,Ultrahigh Frequency Wave,Wave, EHF,Wave, Micro,Wave, Ultrahigh Frequency,Waves, Micro
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014916 Whole-Body Irradiation Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms. Radiation, Whole-Body,Total Body Irradiation,Irradiation, Total Body,Irradiation, Whole-Body,Whole-Body Radiation,Irradiation, Whole Body,Irradiations, Total Body,Irradiations, Whole-Body,Radiation, Whole Body,Radiations, Whole-Body,Total Body Irradiations,Whole Body Irradiation,Whole Body Radiation,Whole-Body Irradiations,Whole-Body Radiations
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
January 1982, Advances in experimental medicine and biology,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
March 1982, Cancer,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
March 1989, Nihon Gan Chiryo Gakkai shi,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
January 1983, Problemy medycyny wieku rozwojowego,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
July 2014, Anticancer research,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
April 1986, Cancer treatment reports,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
May 1995, Radiation research,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
April 1987, Gan no rinsho. Japan journal of cancer clinics,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
January 2002, Anticancer research,
T Satomura, and K Asanuma, and Y Samaru, and M Sekiguchi, and G Fujii
January 1978, Journal of surgical oncology,
Copied contents to your clipboard!